BioSpace News Archive

Press Releases

Greenwich LifeSciences Provides Clinical Updates on FLAMINGO-01

July 20, 2026

·

16 min read

Man jumping, running, and winner holding trophy. Competition, challenge, risk and reward concept. Vector illustration.

Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals

The FDA is currently reviewing Vertex Pharmaceuticals’ povetacicept, with a target action date of Nov. 30. If approved, the drug could benefit from campaigns from Novartis and Vera Therapeutics for their recently approved IgAN therapies Fabhalta and Trutakna.

July 20, 2026

·

2 min read

·

Tristan Manalac

IPO

2026 IPO class blooms again as BlossomHill, Latigo set sights on Nasdaq

Eighteen companies have gone public this year so far, putting 2026 on pace to record the highest number of IPOs since the pandemic-driven high of 2021.

July 20, 2026

·

2 min read

·

Tristan Manalac

Press Releases

Bristol Myers Squibb to Build the Most Powerful AI Factory in Life Sciences with NVIDIA

July 20, 2026

·

6 min read

Art collage, Two hands are shown holding a legal document and a gavel, with scales of justice in the center. The colorful background enhances the theme of law and order, highlighting the importance of justice.

Complete response letters

FDA’s radical transparency policy for rejections runs into legal uncertainty

Having started to publish CRLs without consulting the public, the FDA is under pressure to change course amid concerns it failed to openly and fully evaluate a complex issue.

July 20, 2026

·

5 min read

·

Nick Paul Taylor

Press Releases

Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting

July 20, 2026

·

8 min read

Press Releases

Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World’s Premier Scientific Meetings in Oncology